Version 1
: Received: 16 June 2020 / Approved: 17 June 2020 / Online: 17 June 2020 (09:33:39 CEST)
Version 2
: Received: 8 July 2020 / Approved: 10 July 2020 / Online: 10 July 2020 (01:50:44 CEST)
How to cite:
Huang, M.; Bolin, S.; Miller, H.; Ng, H.L. RORγ Structural Plasticity and Druggability. Preprints2020, 2020060213. https://doi.org/10.20944/preprints202006.0213.v2.
Huang, M.; Bolin, S.; Miller, H.; Ng, H.L. RORγ Structural Plasticity and Druggability. Preprints 2020, 2020060213. https://doi.org/10.20944/preprints202006.0213.v2.
Cite as:
Huang, M.; Bolin, S.; Miller, H.; Ng, H.L. RORγ Structural Plasticity and Druggability. Preprints2020, 2020060213. https://doi.org/10.20944/preprints202006.0213.v2.
Huang, M.; Bolin, S.; Miller, H.; Ng, H.L. RORγ Structural Plasticity and Druggability. Preprints 2020, 2020060213. https://doi.org/10.20944/preprints202006.0213.v2.
Abstract
Retinoic acid receptor-related orphan receptor γ (RORγ) is a transcription factor regulating the expression of the pro-inflammatory cytokine IL-17 in human T helper 17 (Th17) cells. Activating RORγ can induce multiple IL-17-mediated autoimmune diseases but may also be useful for anticancer therapy. Its deep immunological functions make RORɣ an attractive drug target. Over 100 crystal structures have been published describing atomic interactions between RORɣ and agonists and inverse agonists. In this review, we focus on the role of dynamic properties and plasticity of the RORɣ orthosteric and allosteric binding sites by examining structural information from crystal structures and simulated models. We discuss the possible influences of allosteric ligands on the orthosteric binding site. We find that high structural plasticity favors the druggability of RORɣ, especially for allosteric ligands.
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Commenter: Ho Leung Ng
Commenter's Conflict of Interests: Author